Abbvie, INC.
Pharmaceutical researcher and manufacturer
Based in DC
🤖
AI Overview
With $1.4M in lobbying spend across 28 quarterly filings, Abbvie, INC. is a significant lobbying presence.
$1.4M
Total Lobbying Spend
28
Quarterly Filings
1
Lobbying Firms Used
4
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $240K |
| 2019 | $240K |
| 2020 | $240K |
| 2021 | $90K |
| 2022 | $120K |
| 2023 | $150K |
| 2024 | $80K |
| 2025 | $240K |
Lobbying Firms
BAKER & HOSTETLER LLP
What They Lobby For
- Policy issues relating to federal healthcare programs HR 1892, the Bipartisan Budget Act HR 1625, the Consolidated Appropriations Act
- Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid.
- Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare.
- Multiple tax policies, including provisions of the Tax Cuts and Jobs Act.
- Multiple tax policies, including provisions of Public Law No. 115-97 and Public Law No. 119-21.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.